Found 256 matching trials
DRUG ELUTING STENT FOR DIABETIC PATIENTS IN CORONARY ARTERY DISEASE TREATMENT N/A Study Title A post market registry of Abluminus® sirolimus eluting coronary...
Show More Location
IRCCS Pol. San Donato
Learn More & Join Trial
A Pilot Study on Reverse Aging (The REVERSE Study) EARLY_PHASE1 Aging can be defined as a time-dependent functional decline in physiologica...
Show More Status
Active Not Recruiting
Location
AIM for Wellbeing
Learn More & Join Trial
Efficacy and Safety of CertiroBell® Tablet Plus Tacrolimus in Primary Living Donor Liver Transplant Recipients PHASE4 To evaluate the efficacy and safety of CertiroBell® tablet plus tacrolimus...
Location
Seoul National University Hosipital
Learn More & Join Trial
Safety and Effectiveness of the Crystalline Sirolimus-Eluting Device in Patients With Coronary Artery Disease N/A This prospective, multicenter, post-market observational study aims to eval...
Show More Location
Hospital Álvaro Cunqueiro
Learn More & Join Trial
Belatacept to Prevent Organ Rejection in Kidney Transplant Patients PHASE2 Belatacept is an experimental medication shown in clinical trials to have i...
Show More Location
University of California, San Francisco
Learn More & Join Trial
24 Months Follow-up, Two Arm Study to Compare the Cardiovascular Profile in a Regimen With Everolimus + Mycophenolic Acid (MPA) Versus (vs.) a Regimen of CNI+MPA in Maintenance Renal Transplant Recipients PHASE4 The objective of the study is to compare the cardiovascular profile of an e...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcomas With TSC2 or TSC1 Loss-of-function Mutations or Deletions PHASE1 To find a recommended dose of gemcitabine and nab-sirolimus that can be giv...
Show More Location
MD Anderson Cancer Center
Learn More & Join Trial
Tolerance by Engaging Antigen During Cellular Homeostasis PHASE1 Anti-rejection medicines, also known as immunosuppressive drugs, are prescr...
Show More Location
Duke University Health System
Learn More & Join Trial
Calcineurin Inhibitor Based Immunosuppression Withdrawal NA Damage and scarring of a transplanted kidney has become the most common cau...
Show More Location
Pediatric Nephrology of Alabama
Learn More & Join Trial
Safety and Efficacy of Peripheral, Cobalt-chromium Sirolimus Eluting Stent (PERS) Versus Cobalt-chromium Stent (Neptune C) NA The aim of this study is to assess the safety and efficacy of PAD treatment...
Show More Location
Małopolskie Centrum Sercowo-Naczyniowe PAKS American Heart of Poland S.A.
Learn More & Join Trial